<DOC>
	<DOC>NCT00141505</DOC>
	<brief_summary>The study is to evaluate the effect of bifeprunox on the pharmacokinetics of valproate in subjects with Bipolar I Disorder after multiple dose administration.</brief_summary>
	<brief_title>PK Effects of Bifeprunox &amp; Valproate in Bipolar I</brief_title>
	<detailed_description />
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Males or females 1865 years old meeting DSMIV criteria for Bipolar I Disorder, either manic or mixed episodes, with or without psychotic features subjects who are acutely manic, acutely depressed, psychotic or subjects with a current Axis I primary psychiatric diagnosis other than Bipolar I Disorder based on DSMIV TR criteria.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>drug interaction</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>valproate</keyword>
	<keyword>bipolar</keyword>
</DOC>